Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines

Descripción del Articulo

Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous c...

Descripción completa

Detalles Bibliográficos
Autores: Enciso-Benavides, J, Alfaro, L, Castañeda-Altamirano, C, Rojas, N, Gonzalez-Cabeza, J, Enciso, N, Riesco, F, Castillo, M, Enciso, J
Formato: artículo
Fecha de Publicación:2021
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/493
Enlace del recurso:https://hdl.handle.net/20.500.14703/493
Nivel de acceso:acceso abierto
Materia:CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_66cdb9b4dc2f580ae7bba92ac3c61a61
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/493
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
dc.title.none.fl_str_mv Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
spellingShingle Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
Enciso-Benavides, J
CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_full Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_fullStr Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_full_unstemmed Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_sort Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
author Enciso-Benavides, J
author_facet Enciso-Benavides, J
Alfaro, L
Castañeda-Altamirano, C
Rojas, N
Gonzalez-Cabeza, J
Enciso, N
Riesco, F
Castillo, M
Enciso, J
author_role author
author2 Alfaro, L
Castañeda-Altamirano, C
Rojas, N
Gonzalez-Cabeza, J
Enciso, N
Riesco, F
Castillo, M
Enciso, J
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Enciso-Benavides, J
Alfaro, L
Castañeda-Altamirano, C
Rojas, N
Gonzalez-Cabeza, J
Enciso, N
Riesco, F
Castillo, M
Enciso, J
dc.subject.none.fl_str_mv CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors
topic CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous cell population. The objective of this work was to determine differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 TNBT cell lines with the CD44 high /CD24 low phenotype in order to study their exosomes. The results show that the CD44 high /CD24 low MBA-MB-231 cells had a population doubling time of 41.56 h, compared to 44.79 h in the MDA-MB-436 cell line. After magnetic immunoseparation, 18.75% and 14.56% of the stem cell population of the MDA-MB-231 and MDA-MB-436 cell lines, respectively, were of the CD44 high /CD24 low phenotype, which were expanded to reach purities of 80.4% and 87.6%. The same expanded lineage in both cell lines was shown to possess the pluripotency markers Nanog and Oct4. Under a scanning electron microscope, the CD44 high /CD24 low lineage of the MBA-MD-231 cell line formed groups of more interconnected cells than this lineage of the MBA-MD-436 line. A total of 16% of the mice inoculated with the CD44 high /CD24 low lineage of either cell line presented tumours of the breast, lung, and submandibular ganglia, in whose tissues variable numbers of inoculated cells were found 30 days post-inoculation. By magnetic immunoselection, it was possible to isolate in similar quantities and characterize, expand, and xenotransplant the CD44 high /CD24 low lineage of the MDA-MB-231 and MDA-MB-436 cell lines. The former cell line has greater proliferative capacity, the two lines differ under scanning electron microscopy in how they intercommunicate, and both cell lines induce new tumours in mice and persist at least 30 days post-inoculation in the transplanted animal so their exosomes would also be different.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2026-02-16T23:40:25Z
dc.date.available.none.fl_str_mv 2026-02-16T23:40:25Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1016/j.heliyon.2021.e07273
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/493
dc.identifier.journal.none.fl_str_mv National Library of Medicine
identifier_str_mv 10.1016/j.heliyon.2021.e07273
National Library of Medicine
url https://hdl.handle.net/20.500.14703/493
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Heliyon
dc.publisher.country.none.fl_str_mv PE
publisher.none.fl_str_mv Heliyon
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/backend/api/core/bitstreams/9b7eb234-4e02-45af-8fd2-fdc0336ca83c/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/faed8565-3c15-4604-8c2f-4f24db105970/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/ddcff040-0acf-4527-bd8a-1bf0de3e0d97/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/204609ed-a389-429a-913c-4dda6d40e937/download
bitstream.checksum.fl_str_mv 609e2438b330e3af7cc37bf3fb799cf0
bb9bdc0b3349e4284e09149f943790b4
152f4dcf73eb2dafe6e40f1c781637d2
5b57400e86e4373e0c21bbdc34074188
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1868438559831097344
spelling PublicationEnciso-Benavides, JAlfaro, LCastañeda-Altamirano, CRojas, NGonzalez-Cabeza, JEnciso, NRiesco, FCastillo, MEnciso, J2026-02-16T23:40:25Z2026-02-16T23:40:25Z202110.1016/j.heliyon.2021.e07273https://hdl.handle.net/20.500.14703/493National Library of MedicineTriple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous cell population. The objective of this work was to determine differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 TNBT cell lines with the CD44 high /CD24 low phenotype in order to study their exosomes. The results show that the CD44 high /CD24 low MBA-MB-231 cells had a population doubling time of 41.56 h, compared to 44.79 h in the MDA-MB-436 cell line. After magnetic immunoseparation, 18.75% and 14.56% of the stem cell population of the MDA-MB-231 and MDA-MB-436 cell lines, respectively, were of the CD44 high /CD24 low phenotype, which were expanded to reach purities of 80.4% and 87.6%. The same expanded lineage in both cell lines was shown to possess the pluripotency markers Nanog and Oct4. Under a scanning electron microscope, the CD44 high /CD24 low lineage of the MBA-MD-231 cell line formed groups of more interconnected cells than this lineage of the MBA-MD-436 line. A total of 16% of the mice inoculated with the CD44 high /CD24 low lineage of either cell line presented tumours of the breast, lung, and submandibular ganglia, in whose tissues variable numbers of inoculated cells were found 30 days post-inoculation. By magnetic immunoselection, it was possible to isolate in similar quantities and characterize, expand, and xenotransplant the CD44 high /CD24 low lineage of the MDA-MB-231 and MDA-MB-436 cell lines. The former cell line has greater proliferative capacity, the two lines differ under scanning electron microscopy in how they intercommunicate, and both cell lines induce new tumours in mice and persist at least 30 days post-inoculation in the transplanted animal so their exosomes would also be different.application/pdfengHeliyonPEinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/CD44high/CD24low phenotype cellsCancer stem cellsMagnetic immunoselectionTriple-negative breast tumorshttps://purl.org/pe-repo/ocde/ford#3.02.21Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell linesinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALJavier Enciso-Benavides 2021application/pdf3055344https://repositorio.inen.sld.pe/backend/api/core/bitstreams/9b7eb234-4e02-45af-8fd2-fdc0336ca83c/download609e2438b330e3af7cc37bf3fb799cf0MD53trueAnonymousREADLICENSElicense.txtWritten by org.dspace.content.LicenseUtilstext/plain; charset=utf-81748https://repositorio.inen.sld.pe/backend/api/core/bitstreams/faed8565-3c15-4604-8c2f-4f24db105970/downloadbb9bdc0b3349e4284e09149f943790b4MD52falseAnonymousREADTEXTJavier Enciso-Benavides 2021.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2026-02-17T08:00:52Z (GMT).Extracted texttext/plain48400https://repositorio.inen.sld.pe/backend/api/core/bitstreams/ddcff040-0acf-4527-bd8a-1bf0de3e0d97/download152f4dcf73eb2dafe6e40f1c781637d2MD54falseAnonymousREADTHUMBNAILJavier Enciso-Benavides 2021.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2026-02-17T08:00:53Z (GMT).Generated Thumbnailimage/jpeg38282https://repositorio.inen.sld.pe/backend/api/core/bitstreams/204609ed-a389-429a-913c-4dda6d40e937/download5b57400e86e4373e0c21bbdc34074188MD55falseAnonymousREAD20.500.14703/493oai:repositorio.inen.sld.pe:20.500.14703/4932026-02-17T20:23:30.042Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.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
score 12.821158
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).